Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

Paramount Skydance has tabled an improved offer for Warner Bros Discovery in the latest twist in its blockbuster takeover battle with Netflix. The Hollywood studio, whose films include The Godfather ...

Just over a month ago, Anthropic shook the stock market, with fears of a SaaSpocalypse. The AI startup released Claude Cowork, a tool aimed for productivity in the workplace, allowing users to use AI ...